<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00586001</url>
  </required_header>
  <id_info>
    <org_study_id>5R34MH070693-02</org_study_id>
    <nct_id>NCT00586001</nct_id>
  </id_info>
  <brief_title>A Unified Treatment for Anxiety Disorders</brief_title>
  <official_title>Phase 3 of The Development of A Unified Treatment for Anxiety Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University Charles River Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston University Charles River Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a new psychological therapy for a variety of
      different types of emotional disorders. The study will compare symptoms and functioning of
      clients who receive the treatment with those who do not, and will include a number of
      assessments before, during, and after treatment. We predict that patients receiving active
      treatment will show improved functioning relative to wait-list control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Emotional disorders, specifically anxiety disorders and depression, are common, chronic,
      costly, and debilitating to quality of life (Barlow, 2002). Best estimates from various
      epidemiological studies place the one year prevalence of any anxiety disorder for individuals
      over 18 at 11.8%, and the one year prevalence of any mood disorder 5.1% (Narrow, Rae, Robins,
      &amp; Regier, 2002). Lifetime rates are higher. We understand the nature and causes of anxiety
      and unipolar mood disorders (major depressive disorder and dysthymia) somewhat better than 10
      years ago, with evidence pointing to generalized biological and psychological vulnerabilities
      interacting with specific learning and, sometimes, stressful triggering life events as
      etiological factors (Barlow, 2002; Brown, Chorpita, &amp; Barlow, 1998). Pharmacological and
      psychological treatments have been proven effective, at least in the short term, but most
      studies have ignored the effects of treatment on broad-based patterns of comorbidity that
      accompany these disorders. Most comorbid disorders are usually additional emotional disorders
      (Brown, Campbell, Lehman, Grisham, &amp; Mancill, 2001). More importantly, treatment outcomes
      have been less than satisfactory or ineffective for up to 50% of patients, even for the
      principal disorder (Nathan &amp; Gorman, 2002). A common pharmacological treatment exists for
      many emotional disorders, which is selective serotonin re-uptake inhibitors (SSRIs) and
      closely related compounds. Effective psychological treatments, on the other hand, have been
      developed to be very specific to each DSM-IV diagnostic category. The purpose of this
      proposal is to create a unified psychological approach to the emotional disorders. To do,
      this we will take advantage of recent advances in our understanding of the nature of
      emotional disorders, as well as emerging knowledge of the process of regulation and change in
      emotional behavior, in order to distill and refine basic principles of successful
      psychological treatments. It is expected that this approach will simplify training and
      dissemination, possibly improve efficacy, and perhaps also shed further light on the nature
      of emotional disorders. Thus, the specific aims of this proposal are to:

        1. Develop and refine a unified psychological treatment for anxiety and non-bipolar mood
           disorders derived from distilling the major ingredients of current effective approaches
           in light of advancing knowledge of emotion regulation and modification.

        2. Revise and develop methods of evaluating adherence and outcome utilizing this new
           treatment protocol, focusing not only on symptom reduction but also quality of life and
           adaptive functioning.

        3. Treat a small number of patients with heterogeneous DSM-IV mood and anxiety diagnoses
           with this new protocol with the purpose of making appropriate modifications for a
           subsequent pilot study.

        4. Conduct a pilot study testing this unified treatment in comparison to a wait-list
           control condition in order to determine credibility and efficacy in terms of both
           symptomatic functioning and quality of life, and relating these outcomes to those from
           more disorder specific treatments.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Treatment with the Unified Protocol (Arm 1) compared to a 16-week wait list control condition (Arm 2).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety Disorders Interview Schedule for DSM-IV</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>DSM-IV diagnoses of anxiety disorders. Principal and additional diagnoses are assigned a clinical severity rating (CSR) on a scale from 0 (no symptoms) to 8 (extremely severe symptoms), with a rating of 4 or above (definitely disturbing/disabling) passing the clinical threshold for DSM-IV diagnostic criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Structured Interview Guide for the Hamilton Anxiety Rating Scale</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where &lt;17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Reported scores are the mean total scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structured Interview Guide for the Hamilton Depression Rating Scale</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>Structured Interview Guide for the Hamilton Depression Rating Scale, items are scored on scale of 0 to 4, higher score meaning a higher severity. Total scores can range from 0 (no symptoms) to 53 (severe). Reported scores are a mean of the total scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and Negative Affect Scale</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>Positive and Negative Affect Schedule-Negative Affectivity; Positive and Negative Affect Schedule-Positive Affectivity; Items are rated on a scale of 1 (very slightly or not at all) to 5 (extremely) relating to how a person feels average feels the indicated emotion. Total scores can range from 20 to 100. Higher scores are more severe. Reported scores are based on mean totals.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory - II</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>Items are measured on a scale from 0 (little to no symptoms) to 3 (severe). Total scores can range from 0 to 63, higher ratings are more severe. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe. The reported scores are mean total scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>Items are scored on a 0 to 3 scale. Total scores range from 0 to 63. 0-9 is minimal, 10-16 is mild, 17-29 is moderate, and 30-63 is severe. Reported scores are a mean of total scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work and Social Adjustment Scale</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>Items are scored on a 0 to 8 scale. The total score range is 0 to 40. Higher scores are more severe. Reported scores are means of total scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Panic Disorder Severity Scale - Self Report Version</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>Items are rated on a scale of 0 to 4. Scores can range from 0 to 28. Higher scores indicate higher severity of Panic Disorder symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Penn State Worry Questionnaire</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The PSWQ is a 16-item questionnaire. Items are rated from 1 to 5, and a total score can range from 16 to 80. Higher scores indicate higher severity of worry symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social Interaction Anxiety Scale</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The SIAS is a twenty-item measure. Experiences are rated on a 5-point scale from 0 to 4. Experiences are rated on a global period of what is typical. A total score of 60 is possible with cutoffs of 34+ indicative of social phobia and 43+ indicative of social anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Inventory</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The QOLI is a 32 item self-report, asking about the importance of 16 domains of life and a participant's satisfaction in each domain. Scores can range from -48 to 115. Higher scores indicate higher quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The Y-BOCS is a 12-item scale used to see symptom severity of obsessions and compulsions. Items are scored from 0 to 4. The total score can range from 0 to 48. A higher score indicates higher symptom severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotion Regulation Questionnaire - 2</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The ERQ-2 is a 16 item self-report. Items are scored from 1 to 7, and focus on emotional experience and emotional expression. Scores can range from 16 to 112, and higher scores indicate stronger cognitive reappraisal and expressive suppression abilities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BIS/BAS Scales (Carver &amp; White, 1994)</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The Behavioral Inhibition System/Behavioral Approach System Scales is a 20-item self-report where all items can be rated from 0 to 3. The total score can range from 0 to 60. Higher scores indicate higher levels of behavioral inhibition skills.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Affective Control Scale</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The ACS is a 42 item scale where each item is rated from 1 to 7. Scores can range from 42 to 294. Higher scores indicate higher skill levels for controlling emotions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety Sensitivity Index</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The ASI is a 16 item self report where items can be scored from 0 to 4. Scores can range from 0 to 64. Higher scores indicate a higher sensitivity to anxiety and it's symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Thought-Action Fusion Scale (Shafran et al., 1996)</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The TAF is a 19 item self report where each item can be scored from 0 to 4. Scores can range from 0 to 76. Higher scores indicate a higher frequency of maladaptive cognitive intrusions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intolerance of Uncertainty Scale (IUS)</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The IUS is a 27-item self report where each item can be scored from 0 to 4. Scores range from 0 to 108. It rates response to uncertainty, ambiguous situations, and the future. Higher scores indicate higher anxiety and depressive symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Trait Meta-Mood Scale (TMMS; Salovey et al., 1995)</measure>
    <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
    <description>The TMMS is a 48 item self report where each item can be scored from 1 to 5. The three subscales are Attention, Clarity, and Repair. Scores for each of the three subscales can each range from 16 to 80. Higher scores indicate higher emotion regulation skills.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Emotional Disorders</condition>
  <condition>Anxiety Disorders</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Unified Protocol for Transdiagnostic Treatment of Emotional Disorders The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Unified Protocol for Transdiagnostic Treatment of Emotional Disorders</intervention_name>
    <description>Cognitive-behavioral treatment in development for emotional disorders</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary Diagnosis of a DSM-IV Anxiety Disorder

        Exclusion Criteria:

          -  Previous treatment with cognitive-behavioral therapy

          -  Receiving concurrent psychological treatments during study

          -  If on psychotropic medicine, requirement for stable dose for at least three months
             before treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David H Barlow, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University Center for Anxiety and Related Disorders</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.bu.edu/anxiety</url>
    <description>Center for Anxiety and Related Disorders at Boston University webpage</description>
  </link>
  <reference>
    <citation>Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol. 1998 May;107(2):179-92.</citation>
    <PMID>9604548</PMID>
  </reference>
  <reference>
    <citation>Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001 Nov;110(4):585-99.</citation>
    <PMID>11727948</PMID>
  </reference>
  <reference>
    <citation>Barlow DH. Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. Am Psychol. 2000 Nov;55(11):1247-63.</citation>
    <PMID>11280938</PMID>
  </reference>
  <reference>
    <citation>Barlow, D.H., Allen, L., &amp; Choate, M.L. (2006). The Unified Protocol for Treatment of the Emotional Disorders. Unpublished manuscript, Boston University.</citation>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2008</study_first_posted>
  <results_first_submitted>August 3, 2018</results_first_submitted>
  <results_first_submitted_qc>November 26, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 11, 2018</results_first_posted>
  <last_update_submitted>November 26, 2018</last_update_submitted>
  <last_update_submitted_qc>November 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston University Charles River Campus</investigator_affiliation>
    <investigator_full_name>David H. Barlow</investigator_full_name>
    <investigator_title>Professor of Psychology and Psychiatry, Emeritus</investigator_title>
  </responsible_party>
  <keyword>Anxiety</keyword>
  <keyword>Emotional Disorders</keyword>
  <keyword>Unified</keyword>
  <keyword>Depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Unified Treatment</title>
          <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
        </group>
        <group group_id="P2">
          <title>Wait-List Control</title>
          <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Unified Treatment</title>
          <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
        </group>
        <group group_id="B2">
          <title>Wait-list Control</title>
          <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="37"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.38" lower_limit="19" upper_limit="52"/>
                    <measurement group_id="B2" value="30.64" lower_limit="19" upper_limit="43"/>
                    <measurement group_id="B3" value="30.01" lower_limit="19" upper_limit="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Anxiety Disorders Interview Schedule for DSM-IV</title>
        <description>DSM-IV diagnoses of anxiety disorders. Principal and additional diagnoses are assigned a clinical severity rating (CSR) on a scale from 0 (no symptoms) to 8 (extremely severe symptoms), with a rating of 4 or above (definitely disturbing/disabling) passing the clinical threshold for DSM-IV diagnostic criteria.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Anxiety Disorders Interview Schedule for DSM-IV</title>
          <description>DSM-IV diagnoses of anxiety disorders. Principal and additional diagnoses are assigned a clinical severity rating (CSR) on a scale from 0 (no symptoms) to 8 (extremely severe symptoms), with a rating of 4 or above (definitely disturbing/disabling) passing the clinical threshold for DSM-IV diagnostic criteria.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.23" spread="0.89"/>
                    <measurement group_id="O2" value="5.09" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.18" spread="1.55"/>
                    <measurement group_id="O2" value="5.14" spread="0.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Structured Interview Guide for the Hamilton Anxiety Rating Scale</title>
        <description>Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where &lt;17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Reported scores are the mean total scores.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Structured Interview Guide for the Hamilton Anxiety Rating Scale</title>
          <description>Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where &lt;17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Reported scores are the mean total scores.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.15" spread="7.91"/>
                    <measurement group_id="O2" value="14.36" spread="5.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.39" spread="5.37"/>
                    <measurement group_id="O2" value="13.08" spread="4.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Structured Interview Guide for the Hamilton Depression Rating Scale</title>
        <description>Structured Interview Guide for the Hamilton Depression Rating Scale, items are scored on scale of 0 to 4, higher score meaning a higher severity. Total scores can range from 0 (no symptoms) to 53 (severe). Reported scores are a mean of the total scores.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Structured Interview Guide for the Hamilton Depression Rating Scale</title>
          <description>Structured Interview Guide for the Hamilton Depression Rating Scale, items are scored on scale of 0 to 4, higher score meaning a higher severity. Total scores can range from 0 (no symptoms) to 53 (severe). Reported scores are a mean of the total scores.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.35" spread="5.77"/>
                    <measurement group_id="O2" value="10.09" spread="3.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.49" spread="4.63"/>
                    <measurement group_id="O2" value="7.85" spread="4.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Positive and Negative Affect Scale</title>
        <description>Positive and Negative Affect Schedule-Negative Affectivity; Positive and Negative Affect Schedule-Positive Affectivity; Items are rated on a scale of 1 (very slightly or not at all) to 5 (extremely) relating to how a person feels average feels the indicated emotion. Total scores can range from 20 to 100. Higher scores are more severe. Reported scores are based on mean totals.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Positive and Negative Affect Scale</title>
          <description>Positive and Negative Affect Schedule-Negative Affectivity; Positive and Negative Affect Schedule-Positive Affectivity; Items are rated on a scale of 1 (very slightly or not at all) to 5 (extremely) relating to how a person feels average feels the indicated emotion. Total scores can range from 20 to 100. Higher scores are more severe. Reported scores are based on mean totals.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre; Positive Affect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.81" spread="6.27"/>
                    <measurement group_id="O2" value="28.00" spread="7.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post; Positive Affect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.84" spread="6.50"/>
                    <measurement group_id="O2" value="27.17" spread="8.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre; Negative Affect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.62" spread="5.48"/>
                    <measurement group_id="O2" value="24.36" spread="5.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post; Negative Affect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.57" spread="4.95"/>
                    <measurement group_id="O2" value="22.86" spread="7.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Beck Depression Inventory - II</title>
        <description>Items are measured on a scale from 0 (little to no symptoms) to 3 (severe). Total scores can range from 0 to 63, higher ratings are more severe. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe. The reported scores are mean total scores.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Beck Depression Inventory - II</title>
          <description>Items are measured on a scale from 0 (little to no symptoms) to 3 (severe). Total scores can range from 0 to 63, higher ratings are more severe. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe. The reported scores are mean total scores.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.96" spread="7.53"/>
                    <measurement group_id="O2" value="11.73" spread="9.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.21" spread="4.43"/>
                    <measurement group_id="O2" value="11.45" spread="9.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Beck Anxiety Inventory</title>
        <description>Items are scored on a 0 to 3 scale. Total scores range from 0 to 63. 0-9 is minimal, 10-16 is mild, 17-29 is moderate, and 30-63 is severe. Reported scores are a mean of total scores.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Beck Anxiety Inventory</title>
          <description>Items are scored on a 0 to 3 scale. Total scores range from 0 to 63. 0-9 is minimal, 10-16 is mild, 17-29 is moderate, and 30-63 is severe. Reported scores are a mean of total scores.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.08" spread="9.93"/>
                    <measurement group_id="O2" value="16.91" spread="6.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.27" spread="6.51"/>
                    <measurement group_id="O2" value="12.22" spread="7.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Work and Social Adjustment Scale</title>
        <description>Items are scored on a 0 to 8 scale. The total score range is 0 to 40. Higher scores are more severe. Reported scores are means of total scores.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Work and Social Adjustment Scale</title>
          <description>Items are scored on a 0 to 8 scale. The total score range is 0 to 40. Higher scores are more severe. Reported scores are means of total scores.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.04" spread="6.53"/>
                    <measurement group_id="O2" value="16.46" spread="2.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.62" spread="5.40"/>
                    <measurement group_id="O2" value="13.14" spread="3.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Panic Disorder Severity Scale - Self Report Version</title>
        <description>Items are rated on a scale of 0 to 4. Scores can range from 0 to 28. Higher scores indicate higher severity of Panic Disorder symptoms</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-List Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Panic Disorder Severity Scale - Self Report Version</title>
          <description>Items are rated on a scale of 0 to 4. Scores can range from 0 to 28. Higher scores indicate higher severity of Panic Disorder symptoms</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.65" spread="5.68"/>
                    <measurement group_id="O2" value="7.09" spread="7.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.77" spread="3.01"/>
                    <measurement group_id="O2" value="6.20" spread="7.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Penn State Worry Questionnaire</title>
        <description>The PSWQ is a 16-item questionnaire. Items are rated from 1 to 5, and a total score can range from 16 to 80. Higher scores indicate higher severity of worry symptoms.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-List Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Penn State Worry Questionnaire</title>
          <description>The PSWQ is a 16-item questionnaire. Items are rated from 1 to 5, and a total score can range from 16 to 80. Higher scores indicate higher severity of worry symptoms.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.27" spread="11.54"/>
                    <measurement group_id="O2" value="62.55" spread="10.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.18" spread="13.89"/>
                    <measurement group_id="O2" value="60.30" spread="15.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Social Interaction Anxiety Scale</title>
        <description>The SIAS is a twenty-item measure. Experiences are rated on a 5-point scale from 0 to 4. Experiences are rated on a global period of what is typical. A total score of 60 is possible with cutoffs of 34+ indicative of social phobia and 43+ indicative of social anxiety.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-List Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Social Interaction Anxiety Scale</title>
          <description>The SIAS is a twenty-item measure. Experiences are rated on a 5-point scale from 0 to 4. Experiences are rated on a global period of what is typical. A total score of 60 is possible with cutoffs of 34+ indicative of social phobia and 43+ indicative of social anxiety.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.19" spread="17.99"/>
                    <measurement group_id="O2" value="38.18" spread="20.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.32" spread="16.76"/>
                    <measurement group_id="O2" value="37.60" spread="20.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life Inventory</title>
        <description>The QOLI is a 32 item self-report, asking about the importance of 16 domains of life and a participant's satisfaction in each domain. Scores can range from -48 to 115. Higher scores indicate higher quality of life.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life Inventory</title>
          <description>The QOLI is a 32 item self-report, asking about the importance of 16 domains of life and a participant's satisfaction in each domain. Scores can range from -48 to 115. Higher scores indicate higher quality of life.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.46" spread="19.52"/>
                    <measurement group_id="O2" value="32.45" spread="10.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.73" spread="14.00"/>
                    <measurement group_id="O2" value="34.67" spread="11.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Yale-Brown Obsessive Compulsive Scale</title>
        <description>The Y-BOCS is a 12-item scale used to see symptom severity of obsessions and compulsions. Items are scored from 0 to 4. The total score can range from 0 to 48. A higher score indicates higher symptom severity.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-List Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Yale-Brown Obsessive Compulsive Scale</title>
          <description>The Y-BOCS is a 12-item scale used to see symptom severity of obsessions and compulsions. Items are scored from 0 to 4. The total score can range from 0 to 48. A higher score indicates higher symptom severity.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.81" spread="9.47"/>
                    <measurement group_id="O2" value="7.18" spread="9.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.09" spread="8.17"/>
                    <measurement group_id="O2" value="8.65" spread="8.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Emotion Regulation Questionnaire - 2</title>
        <description>The ERQ-2 is a 16 item self-report. Items are scored from 1 to 7, and focus on emotional experience and emotional expression. Scores can range from 16 to 112, and higher scores indicate stronger cognitive reappraisal and expressive suppression abilities.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Emotion Regulation Questionnaire - 2</title>
          <description>The ERQ-2 is a 16 item self-report. Items are scored from 1 to 7, and focus on emotional experience and emotional expression. Scores can range from 16 to 112, and higher scores indicate stronger cognitive reappraisal and expressive suppression abilities.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.40" spread="16.82"/>
                    <measurement group_id="O2" value="60.36" spread="22.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.95" spread="15.74"/>
                    <measurement group_id="O2" value="60.00" spread="18.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>BIS/BAS Scales (Carver &amp; White, 1994)</title>
        <description>The Behavioral Inhibition System/Behavioral Approach System Scales is a 20-item self-report where all items can be rated from 0 to 3. The total score can range from 0 to 60. Higher scores indicate higher levels of behavioral inhibition skills.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>BIS/BAS Scales (Carver &amp; White, 1994)</title>
          <description>The Behavioral Inhibition System/Behavioral Approach System Scales is a 20-item self-report where all items can be rated from 0 to 3. The total score can range from 0 to 60. Higher scores indicate higher levels of behavioral inhibition skills.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment BIS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.15" spread="3.41"/>
                    <measurement group_id="O2" value="24.45" spread="2.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment BIS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.32" spread="4.14"/>
                    <measurement group_id="O2" value="23.60" spread="2.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre-Treatment BAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.09" spread="6.55"/>
                    <measurement group_id="O2" value="35.18" spread="7.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment BAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.27" spread="5.78"/>
                    <measurement group_id="O2" value="35.40" spread="8.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Affective Control Scale</title>
        <description>The ACS is a 42 item scale where each item is rated from 1 to 7. Scores can range from 42 to 294. Higher scores indicate higher skill levels for controlling emotions</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Affective Control Scale</title>
          <description>The ACS is a 42 item scale where each item is rated from 1 to 7. Scores can range from 42 to 294. Higher scores indicate higher skill levels for controlling emotions</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140.92" spread="26.48"/>
                    <measurement group_id="O2" value="141.00" spread="35.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106.36" spread="25.34"/>
                    <measurement group_id="O2" value="141.60" spread="40.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anxiety Sensitivity Index</title>
        <description>The ASI is a 16 item self report where items can be scored from 0 to 4. Scores can range from 0 to 64. Higher scores indicate a higher sensitivity to anxiety and it's symptoms.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Anxiety Sensitivity Index</title>
          <description>The ASI is a 16 item self report where items can be scored from 0 to 4. Scores can range from 0 to 64. Higher scores indicate a higher sensitivity to anxiety and it's symptoms.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.62" spread="11.56"/>
                    <measurement group_id="O2" value="29.27" spread="10.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.36" spread="12.75"/>
                    <measurement group_id="O2" value="25.50" spread="12.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Thought-Action Fusion Scale (Shafran et al., 1996)</title>
        <description>The TAF is a 19 item self report where each item can be scored from 0 to 4. Scores can range from 0 to 76. Higher scores indicate a higher frequency of maladaptive cognitive intrusions.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>The Thought-Action Fusion Scale (Shafran et al., 1996)</title>
          <description>The TAF is a 19 item self report where each item can be scored from 0 to 4. Scores can range from 0 to 76. Higher scores indicate a higher frequency of maladaptive cognitive intrusions.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.46" spread="14.03"/>
                    <measurement group_id="O2" value="16.82" spread="15.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.43" spread="9.67"/>
                    <measurement group_id="O2" value="16.90" spread="17.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intolerance of Uncertainty Scale (IUS)</title>
        <description>The IUS is a 27-item self report where each item can be scored from 0 to 4. Scores range from 0 to 108. It rates response to uncertainty, ambiguous situations, and the future. Higher scores indicate higher anxiety and depressive symptoms.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Intolerance of Uncertainty Scale (IUS)</title>
          <description>The IUS is a 27-item self report where each item can be scored from 0 to 4. Scores range from 0 to 108. It rates response to uncertainty, ambiguous situations, and the future. Higher scores indicate higher anxiety and depressive symptoms.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.38" spread="20.14"/>
                    <measurement group_id="O2" value="39.27" spread="21.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.77" spread="19.57"/>
                    <measurement group_id="O2" value="40.25" spread="28.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Trait Meta-Mood Scale (TMMS; Salovey et al., 1995)</title>
        <description>The TMMS is a 48 item self report where each item can be scored from 1 to 5. The three subscales are Attention, Clarity, and Repair. Scores for each of the three subscales can each range from 16 to 80. Higher scores indicate higher emotion regulation skills.</description>
        <time_frame>Measured at pre-treatment (baseline) and post-treatment (month 3)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Unified Treatment</title>
            <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
          </group>
          <group group_id="O2">
            <title>Wait-list Control</title>
            <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>The Trait Meta-Mood Scale (TMMS; Salovey et al., 1995)</title>
          <description>The TMMS is a 48 item self report where each item can be scored from 1 to 5. The three subscales are Attention, Clarity, and Repair. Scores for each of the three subscales can each range from 16 to 80. Higher scores indicate higher emotion regulation skills.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment Attention Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.83" spread="8.84"/>
                    <measurement group_id="O2" value="76.50" spread="9.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre-Treatment Clarity Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.83" spread="7.65"/>
                    <measurement group_id="O2" value="51.30" spread="11.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre-Treatment Repair Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.43" spread="4.40"/>
                    <measurement group_id="O2" value="37.40" spread="4.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment Attention Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.68" spread="8.12"/>
                    <measurement group_id="O2" value="76.00" spread="11.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment Clarity Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.69" spread="7.91"/>
                    <measurement group_id="O2" value="54.31" spread="11.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment Repair Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.59" spread="4.42"/>
                    <measurement group_id="O2" value="37.89" spread="5.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Unified Treatment</title>
          <description>Unified treatment: The UP is a form of transdiagnostic cognitive-behavioral therapy (CBT) for individuals diagnosed with anxiety disorders, depression and related disorders.</description>
        </group>
        <group group_id="E2">
          <title>Wait-list Control</title>
          <description>Wait-list control: Participants were asked to wait 16 weeks before receiving treatment.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Todd Farchione</name_or_title>
      <organization>Boston University Charles River Campus</organization>
      <phone>(617) 353-9610</phone>
      <email>tfarchio@bu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

